The GAVI Alliance Board Have Approved a Framework That Will Support The Immunisation of an Additional 300 Million Children in Developing Countries

Record numbers of children protected against leading causes of pneumonia with Gavi support

“la Caixa” Foundation announces further €1m commitment to support pneumococcal vaccine November 12, 2014 More children than ever before are being protected against the leading causes of pneumonia as countries strengthen their immunisation programmes with support from Gavi, the Vaccine Alliance. In 2013 alone, almost 40 million children in developing countries received the pentavalent vaccine, which includes protection against Haemophilus Influenzae type b …

Interactive Map: Advance market commitment for pneumococcal vaccines

This map shows the availability of pneumococcal vaccines PCV10 and PCV13 through the Advanced Market Commitment scheme designed to get life saving vaccines to the developing world as fast and reliably as possible. *Source: Advance Market Commitment for Pnewumococcal Vaccines, Annual Report 1 April 2013 – 31 March 2014, prepared by the GAVI Alliance Click here to see our Advance …

Pneumococcal Conjugate Vaccine for Adults: A New Paradigm

  In April 2013 over 500 delegates participated in the 13th Annual World Vaccine Congress Washington. This event brings together vaccine leaders and policy makers from around the globe. Attendees at this highly successful event were fortunate enough to hear this exciting presentation delivered by William Gruber, Pfizer entitled: ‘Pneumococcal Conjugate Vaccine for Adults: A New Paradigm'This presentation outlines: Efficacy …